MX2020004660A - Control de nivel de glucosa fuera de linea basado en periodos anteriores de control de nivel de glucosa en linea. - Google Patents

Control de nivel de glucosa fuera de linea basado en periodos anteriores de control de nivel de glucosa en linea.

Info

Publication number
MX2020004660A
MX2020004660A MX2020004660A MX2020004660A MX2020004660A MX 2020004660 A MX2020004660 A MX 2020004660A MX 2020004660 A MX2020004660 A MX 2020004660A MX 2020004660 A MX2020004660 A MX 2020004660A MX 2020004660 A MX2020004660 A MX 2020004660A
Authority
MX
Mexico
Prior art keywords
insulin
control parameters
doses
offline
online operation
Prior art date
Application number
MX2020004660A
Other languages
English (en)
Inventor
Edward R Damiano
Firas H El-Khatib
Original Assignee
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Boston filed Critical Univ Boston
Publication of MX2020004660A publication Critical patent/MX2020004660A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14288—Infusion or injection simulation
    • A61M2005/14296—Pharmacokinetic models
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0486—Glucose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/07—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/005—Parameter used as control input for the apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Abstract

Aparatos y métodos para calcular y suministrar dosis de insulina y, opcionalmente, glucagón en un sujeto. La operación en línea controla el suministro de dosis de corrección de insulina automáticamente en respuesta a mediciones periódicas de glucosa de un sensor, y la operación fuera de línea calcula y suministra dosis de corrección con base en mediciones aisladas de glucosa y la información recolectada de forma autónoma durante una operación en línea anterior. En otro aspecto, la operación fuera de línea incluye calcular y administrar de forma automática dosis de alimentos con base en la información recolectada de forma autónoma durante periodos anteriores de operación en línea. Ambos métodos incluyen generar parámetros de control relevantes adecuados para el individuo y continuamente convergentes tras, y modulados potencialmente, durante la operación en línea. Los parámetros de control se emplean en tiempo real durante los periodos de operación fuera de línea para regular el nivel de glucosa sin la necesidad de parámetros de control proporcionados por el usuario, tales como factores de corrección y relaciones de insulina a carbohidratos.
MX2020004660A 2014-01-31 2016-07-27 Control de nivel de glucosa fuera de linea basado en periodos anteriores de control de nivel de glucosa en linea. MX2020004660A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461933996P 2014-01-31 2014-01-31

Publications (1)

Publication Number Publication Date
MX2020004660A true MX2020004660A (es) 2020-07-24

Family

ID=53757655

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016009787A MX2016009787A (es) 2014-01-31 2015-01-26 Control de nivel de glucosa fuera de linea basado en periodos anteriores de control de nivel de glucosa en linea.
MX2020004660A MX2020004660A (es) 2014-01-31 2016-07-27 Control de nivel de glucosa fuera de linea basado en periodos anteriores de control de nivel de glucosa en linea.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016009787A MX2016009787A (es) 2014-01-31 2015-01-26 Control de nivel de glucosa fuera de linea basado en periodos anteriores de control de nivel de glucosa en linea.

Country Status (10)

Country Link
US (1) US10543313B2 (es)
EP (2) EP3089667B1 (es)
JP (1) JP6243546B2 (es)
CN (2) CN106456064B (es)
AU (2) AU2015211258A1 (es)
CA (1) CA2938078C (es)
DK (1) DK3089667T3 (es)
IL (1) IL246934B (es)
MX (2) MX2016009787A (es)
WO (1) WO2015116524A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9629901B2 (en) * 2014-07-01 2017-04-25 Bigfoot Biomedical, Inc. Glucagon administration system and methods
US9943645B2 (en) * 2014-12-04 2018-04-17 Medtronic Minimed, Inc. Methods for operating mode transitions and related infusion devices and systems
EP3319511B1 (en) 2015-08-07 2021-10-06 Trustees of Boston University Glucose control system with automatic adaptation of glucose target
JP6941165B2 (ja) * 2016-09-30 2021-09-29 ノボ・ノルデイスク・エー／エス 薬剤注射の分布の平均およびばらつきを表す用量履歴を通信するシステムおよび方法
US11147920B2 (en) * 2017-04-18 2021-10-19 Lifescan Ip Holdings, Llc Diabetes management system with automatic basal and manual bolus insulin control
CA3059985C (en) 2017-05-05 2023-08-08 Eli Lilly And Company Closed loop control of physiological glucose
GB201710822D0 (en) * 2017-07-05 2017-08-16 Zealand Pharma As Methods and medical uses relating to the treatment of hypoglycaemia
CN111542884B (zh) 2017-12-21 2024-03-15 益首药物治疗股份公司 生理葡萄糖的闭环控制
JP7124120B2 (ja) * 2018-05-04 2022-08-23 インスレット コーポレイション 制御アルゴリズムベースの薬物送達システムのための安全制約
US11071821B2 (en) * 2018-09-28 2021-07-27 Medtronic Minimed, Inc. Insulin infusion device with efficient confirmation routine for blood glucose measurements
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
MX2022000670A (es) 2019-07-16 2022-05-20 Beta Bionics Inc Sistema de control de glucosa en sangre.
CN114787935A (zh) 2019-07-16 2022-07-22 贝塔仿生公司 血糖控制系统
CN114868200A (zh) 2019-10-04 2022-08-05 贝塔仿生公司 血糖控制系统
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
US20220265143A1 (en) 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US11610661B2 (en) 2020-12-07 2023-03-21 Beta Bionics, Inc. Ambulatory medicament pump with safe access control
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
WO2023070253A1 (en) * 2021-10-25 2023-05-04 Medtrum Technologies Inc. Closed-loop artificial pancreas insulin infusion control system

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK85633C (da) 1953-09-04 1958-06-02 Gestetner Ltd Duplikeringsmaskine.
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US20040253736A1 (en) * 2003-06-06 2004-12-16 Phil Stout Analytical device with prediction module and related methods
WO2005113036A1 (en) * 2004-05-13 2005-12-01 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
WO2006124716A2 (en) * 2005-05-13 2006-11-23 Trustees Of Boston University Fully automated control system for type 1 diabetes
US20060272652A1 (en) * 2005-06-03 2006-12-07 Medtronic Minimed, Inc. Virtual patient software system for educating and treating individuals with diabetes
CN100446724C (zh) * 2005-11-28 2008-12-31 中国科学院电子学研究所 用于闭环胰岛素注射的无创血糖仪
JP4918285B2 (ja) * 2006-05-24 2012-04-18 シスメックス株式会社 生体器官の機能のシミュレーションシステム及びそのプログラム
WO2007149533A2 (en) 2006-06-19 2007-12-27 Dose Safety System, method and article for controlling the dispensing of insulin
US20110054391A1 (en) * 2006-07-28 2011-03-03 Ward W Kenneth Analyte sensing and response system
US10154804B2 (en) * 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US7751907B2 (en) 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
US8454510B2 (en) 2007-06-20 2013-06-04 Medingo Ltd. Method and device for assessing carbohydrate-to-insulin ratio
CN101821741B (zh) * 2007-06-27 2013-12-04 霍夫曼-拉罗奇有限公司 用于被调用事件的医学诊断、治疗和预后系统及其方法
CN102670209A (zh) * 2007-09-07 2012-09-19 泰尔茂株式会社 血糖值测量方法
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8185412B1 (en) * 2008-03-28 2012-05-22 Mahesh Harpale Method and apparatus for chronic care treatment control with custom named-type factors and user estimation error correction
EP2283373B1 (en) * 2008-04-28 2021-03-10 Cornell University Accurate quantification of magnetic susceptibility in molecular mri
CN201186082Y (zh) * 2008-05-05 2009-01-28 王安宇 胰岛素、葡萄糖智能输入装置
US7959598B2 (en) * 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US8527208B2 (en) * 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
AU2010210157B2 (en) * 2009-02-04 2014-08-28 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing information for glycemic control
EP4231307A1 (en) 2009-05-29 2023-08-23 University Of Virginia Patent Foundation System coordinator and modular architecture for open-loop and closed-loop control of diabetes
WO2011028731A1 (en) 2009-09-01 2011-03-10 University Of Virginia Patent Foundation System, method and computer program product for adjustment of insulin delivery (aid) in diabetes using nominal open-loop profiles
EP2477613B1 (en) 2009-09-18 2017-10-18 Roche Diabetes Care GmbH Devices, systems and methods for quantifying bolus doses according to user parameters
WO2011039741A1 (en) * 2009-09-30 2011-04-07 Mor Research Applications Ltd. Monitoring device for mangement of insulin delivery
AU2011207425A1 (en) * 2010-01-25 2012-08-16 Ventria Bioscience Methods and compositions for improving protein production
EP2521483B1 (en) * 2010-02-11 2016-08-17 The Regents of The University of California System to deliver insulin to a subject
US8579879B2 (en) * 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
AU2010346624A1 (en) * 2010-02-25 2012-09-06 Lifescan Scotland Limited Analyte testing method and system with safety warnings for insulin dosing
US10561785B2 (en) * 2010-06-22 2020-02-18 Medtronic Minimed, Inc. Method and/or system for closed-loop control of glucose to a treatment range
CN102346961A (zh) * 2010-07-29 2012-02-08 鸿富锦精密工业（深圳）有限公司 电子设备
JP6047097B2 (ja) * 2010-10-31 2016-12-21 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム
WO2012108938A1 (en) * 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Software applications residing on handheld analyte determining devices

Also Published As

Publication number Publication date
CA2938078A1 (en) 2015-08-06
AU2017251868A1 (en) 2017-11-16
EP4091541A1 (en) 2022-11-23
CN106456064B (zh) 2020-11-27
CA2938078C (en) 2019-06-11
CN112515665B (zh) 2024-03-29
EP3089667A4 (en) 2017-09-13
CN106456064A (zh) 2017-02-22
AU2015211258A1 (en) 2016-08-11
US10543313B2 (en) 2020-01-28
MX2016009787A (es) 2017-02-22
IL246934B (en) 2021-05-31
CN112515665A (zh) 2021-03-19
AU2017251868B2 (en) 2019-07-11
EP3089667B1 (en) 2022-04-13
WO2015116524A1 (en) 2015-08-06
JP2017511911A (ja) 2017-04-27
DK3089667T3 (da) 2022-05-09
IL246934A0 (en) 2016-09-29
EP3089667A1 (en) 2016-11-09
JP6243546B2 (ja) 2017-12-06
US20160331898A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
MX2020004660A (es) Control de nivel de glucosa fuera de linea basado en periodos anteriores de control de nivel de glucosa en linea.
AU2023200730B2 (en) Distributed system architecture for continuous glucose monitoring
AU2022204311B2 (en) Inhalation monitoring system and method
MX2022002141A (es) Aparatos, sistemas y metodos de entrega de semillas.
MY184899A (en) Non-burning type flavor inhaler and control method
EP3957233A3 (en) Glucose control system with automatic adaptation of glucose target
EP4079383A3 (en) Method and system for interacting with a virtual environment
MX2018003342A (es) Formulacion de prevaporizacion para controlar la acidez en un dispositivo de vapeo electronico.
PH12016502033B1 (en) Aerosol-generating system for delivering nicotine salt particles
EP3216003A4 (en) Method and platform/system for creating a web-based form that incorporates an embedded knowledge base, wherein the form provides automatic feedback to a user during and following completion of the form
MX2017005300A (es) Metodo, sistema y dispositivo generador de aerosol con un detector de gas de combustion.
MY189466A (en) Methods of modulating drug plasma levels using erythrohydroxybupropion
MX2017006268A (es) Administracion intranasal.
MX2021008173A (es) Metodo y aparato de administracion transdermica de medicamentos.
WO2014035672A3 (en) Safeguarding techniques for a closed-loop insulin infusion system
EP3157417A4 (en) System and method for improved cardiac rhythm classification from time between heart beat intervals using non-linear dynamics
PH12016501621A1 (en) Automated on demand baking system
MX348448B (es) Aparato de guia de respiracion para salas de parto.
AU2024202189A1 (en) Blood glucose rate of change modulation of meal and correction insulin bolus quantity
PT3110840T (pt) A22k, desb27, b29r, des b30, na posição épsilon de análogo de insulina humana acilada de lisina 22
WO2016166059A3 (en) A method, a computer program product and a system for optimization of radiotherapy treatment planning
EP3102296A4 (en) Method and system for providing feedback automatically on physiological measurements to a user
EP3148232A4 (en) Method, device and system for controlling total quantity of online attached users
WO2014029810A3 (en) Insulin pump and methods for operating the insulin pump
MX2016010415A (es) Metodos para usar sistemas de suministro de herbicidas solidas estables.